Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Microbot Medical Inc.

Microbot Medical Inc. (MBOT) Stock Overview

Explore Microbot Medical Inc.’s financial performance, market position, analyst ratings, and future outlook.

MBOT●NASDAQ
HealthcareMedical - Instruments & Supplies
$1.71
$0.05(2.84%)
U.S. Market opens in 14h 27m

Microbot Medical Inc. (MBOT)

Meyka AI Score

Z

Key Financials

Market Cap77.9M
P/E Ratio-6.16
EPS (TTM)$-0.26
ROE-0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$2.51
3 Months$1.57
1 Year Target$2.40

MBOT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Microbot Medical Inc. (NASDAQ: MBOT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Microbot Medical Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MBOT on the NASDAQ shows an RSI of 35.42, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.40 for the NASDAQ listing.

Key metrics behind Microbot Medical Inc.'s NASDAQ-traded stock include a P/E ratio of -6.16 and a market capitalization of 77.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MBOT on the NASDAQ.

Price Performance (NASDAQ: MBOT)

1-Day Change
-2.84%
5-Day Change
-3.93%
1-Month Change
-4.47%
3-Month Change
-22.27%
6-Month Change
-13.64%
Year-to-Date (YTD) Change
-14.50%
1-Year Change
-37.59%
3-Year Change
-31.33%
5-Year Change
-76.08%
All-Time (Max) Change
-100.00%

Contact Information

https://www.microbotmedical.com
781 875 3605
175 Derby Street, Hingham, MA, 02043

Company Facts

430 Employees
IPO DateMar 25, 1992
CountryUS
Actively Trading

Frequently Asked Questions